Tim LaBua Photo

Industry Experience

Tim is highly adept at counseling emerging growth life science companies in connection with a variety of financing and strategic partnership challenges, as well as merger and acquisition transactions. He also has extensive experience representing publicly-traded companies and helping business development teams navigate the complexities of early-stage strategic investments and purchase options.

experience +

experience –

Skadden, Arps, Slate, Meagher & Flom LLP

Associate Attorney

Wilmer Cutler Pickering Hale & Dorr LLP

Associate Attorney

  • Investment & Operations Counsel at prominent value-focused hedge fund

Recent Client Work +

Recent Client WOrk –

  • GV in its purchase of preferred equity in Endcadia, Inc.
  • Apic Bio, Inc. in its Series A Financing
  • XyloCor Therapeutics, Inc. in its Series A Financing
  • Venn Biosciences Corporation in its Series A Financing
  • Guardian Therapeutics, LLC in its acquisition of Band Therapeutics, LLC
  • Kantum Diagnostics, Inc. in its convertible debt financing
  • Synedgen, Inc. in its out-license of IP and sale of assets to Synspira, LLC
  • Synspira, LLC in its equity/debt financing and research funding from The Cystic Fibrosis Foundation Trust
  • Profit Tools, Inc. in its sale of certain assets to Valsoft Corporation
  • FOG Pharmaceuticals, Inc. in its Series B Financing
  • LifeMine Therapeutics, Inc. in its Series A Financing
  • Renoviso, Inc. in its Series A-1 Financing
  • Lundbeckfond Ventures in its sale of certain royalty rights
  • Bio-Pharm, Inc. in its acquisition by Torrent Pharmaceuticals Ltd.
  • Hexcel Corporation in its acquisition of the aerospace and defense business of Oxford Performance Materials, Inc.
  • Alnylam Pharmaceuticals, Inc. in its strategic collaboration with Vir Biotechnology to develop RNAi therapeutics for infectious diseases
  • .406 Ventures, LLC in its purchase of preferred equity in Trilio Data, Inc.
  • .406 Ventures, LLC as selling shareholder in the acquisition of Jisto, Inc. by Trilio Data, Inc.
  • VivoPharm Pty. Ltd. in its acquisition by Cancer Genetics, Inc.
  • GO Therapeutics, Inc. in its Series A-1 Financing
  • Lysosomal Therapeutics, Inc. in its exclusive option arrangement with Allergan plc
  • PTC Therapeutics, Inc. in its Senior Secured Term Loan Facility
  • Hexcel Corporation in its strategic investment in Carbon Conversions, Inc.

Community +

Community –

Bar Admissions
  • Massachusetts
Education
  • University of Michigan Law School, Dean's Scholarship
  • Brown University, B.A.